CrossrefInfokarte
Correction to: Targeting of acute myeloid leukemia by five-gene engineered T cells expressing transgenic T-cell receptor specific to WT1, chimeric antigenic receptor specific to GM-CSF receptor, bispecific T-cell engager specific to CD33, and tEGFR suicide gene system
Immunotherapy Advances · 2025-12-31 · 6 (1)
DOI: 10.1093/immadv/ltag025 ↗Abstract
Kein Abstract verfügbar.
EUVIMED